Molecular mechanisms involved in T-B interactions

Chemical Immunology

Volumn 67, Issue , 1997, Pages 1-13

  Lane, Peter ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANTIBODY PRODUCTION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; DENDRITIC CELL; HELPER CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SOMATIC MUTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030974138     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058674     Document Type: Review

References (65)

1. Hoogenboom HR, Marks JD, Griffiths AD, Winter G: Building antibodies from their genes. Immunol Rev 1992;130:41-68.
2. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR: Making antibodies by phage display technology. Annu Rev Immunol 1994;12:433-455.
3. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296.
4. Cella M, Scheidegger D, Palmer-Lehman K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell costimulatory capacity: T-T help via APC activation. J Exp Med, in press.
5. Grewal IS, Xu J, Flavell RA: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995;378:617-619.
6. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P: Successful T cell priming in B cell-deficient mice. J Exp Med 1995;182:915-922.
7. Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK: Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992;176: 1595-1604.
8. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
9. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
10. Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-988.
11. Ronchese F, Hausmann B, Hubele S, Lane P: Normal T cell priming to a protein antigen in mice transgenic for soluble CTLA-4. J Exp Med 1994;179:809-817.
12. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB: Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994;1:501-508.
13. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261:609-612.
14. Lane P, Burdet C, Hubele S, Scheidegger D, Müller U, McConnell F, Kosco-Villbois M: B cell function in mice transgenic for mCTLA4-H gamma 1: Lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J Exp Med 1994;179:819-830.
15. Cohen PL, Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-269.
16. Singer GG, Abbas AA: The fas antigen is involved in peripheral but not thymic deletion of T cells in T cell receptor transgenic mice. Immunity 1994;1:365-371.
17. Smith KG, Nossal GJ, Tarlinton DM: FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA 1995;92:11628-11632.
18. Lane P, Haller C, McConnell F: Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects Vβ8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur J Immunol 1996;26:858-862.
19. Vyth Dreese FA, Dellemijn TA, Majoor D, de Jong D: Localization in situ of the costimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur J Immunol 1995;25:3023-3029.
20. Marengere LEM, Waterhouse P, Duncan GS, Mittrücker H, Feng G, Mak TW: Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996;272:1170-1173.
21. Jacobsen BA, Panka DJ, Nguyen K, Erikson J, Abbas AK, Marshak-Rothstein A: Anatomy of autoandibody production: Dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 1995;3:509-519.
22. Stockinger B, Zal T, Zal A, Gray D: B cells solicit their own help from T cells. J Exp Med 1995;183: 891-899.
23. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC: CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995; 376:181-184.
24. Jacob J, Kassir R, Kelsone G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 1991;173:1165-1176.
25. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635-673.
26. Stalder T, Hahn S, Erb P: Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994;152:1127-1133.
27. Kopf M, Le-Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
28. Mason D: The role of B cells in the programming of T cells for IL-4 synthesis. J Exp Med 1996;183: 717-719.
29. van Essen D, Kikutani H, Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995;378:620-623.
30. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993;177:925-935.
31. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G: Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 1995;155: 556-567.
32. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.
33. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-532.
34. Lens SMA, Keehnen RMJ, Van Oers MHJ, van Lier RAW, Pals ST, Koopman G: Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. Eur J Immunol 1996;26:1007-1011.
35. Hintzen RQ, de-Jong R, Lens SM, van-Lier RA: CD27: Marker and mediator of T-cell activation? Immunol Today 1994;15:307-311.
36. Stüber E, Neurath M, Calderhead D, Fell HP, Strober W: Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2:507-521.
37. Stüber E, Strober W: The T cell-B interaction via OX40-OX40L is necessary for the cell-dependent. J Exp Med 1996;183:979-989.
38. Fearon DT, Carter RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu Rev Immunol 1995;13:127-149.
39. Rickert RC, Rajewsky K, Roes J: Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995;376:352-355.
40. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39-50.
41. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD: Role of lymphotoxin and type 1 TNF receptor in the formation of germinal centers. Science 1996;271:1289-1291.
42. Kepler TB, Perelson AS: Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. Immunol Today 1993;14:412-415.
43. Jacob J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 1992;176:679-687.
44. Betz AG, Neuberger MS, Milstein C: Discriminating intrinsic and antigen-selected mutational hot-spots in immunoglobulin V genes. Immunol Today 1993;14:405-411.
45. Zhang J, MacLennan ICM, Liu Y-J, Lane PJL: Is rapid proliferation in B centroblasts linked to somatic mutation in memory B cell clones? Immunol Lett 1988;18:297-300.
46. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC: Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991;21:2951-2962.
47. Kawabe T, Naka T, Yoshida K, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune response in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167-178.
48. Xu J, Foy TM, Laman JD, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1994;1:423-431.
49. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ: gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994; 180:157-163.
50. Galibert L, van-Dooren J, Durand I, Rousset F, Jefferis R, Banchereau J, Lebecque S: Anti-CD40 plus interleukin-4-activated human naive B cell lines express unmutated immunoglobulin genes with intraclonal heavy chain isotype variability. Eur J Immunol 1995;25:733-737.
51. Källberg E, Jainandunsing S, Gray D, Leanderson T: Somatic mutation of immunoglobulin V genes in vitro. Science 1996;271:1285-1289.
52. Miller C, Stedra J, Kelsoe G, Cerny J: Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes. J Exp Med 1995;181:1319-1331.
53. Lane P, Burdet C, McConnell F, Lanzavecchia A, Padovan E: CD40 ligand independent B cell activation revealed by CD40-ligand deficient T cell clones: Evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur J Immunol 1995;25:1788-1793.
54. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen-driven-selection in germinal centres. Nature 1989;342:929-931.
55. Arpin C, Dechanet J, Van Kooten C, Merveille P, Grouard G, Briere F, Banchereau J, Liu YJ: Generation of memory B cells and plasma cells in vitro. Science 1995;268:720-722.
56. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-356.
57. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W: CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 1990;20:2679-2684.
58. Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, Holter W, Knapp W: IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992; 148:3700-3705.
59. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C: CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci USA 1995;92:11249-11253.
60. Agematsu K, Kobata T, Yang FC, Nakazawa T, Fukushima K, Kitahara M, Mori T, Sugita K, Morimoto C, Komiyama A: CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995;25:2825-2829.
61. Liu Y-J, Oldfield S, MacLennan I: Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988;18:355-362.
62. Liu YJ, Barthelemy C, de Bouteiller O, Arpin C, Durand I, Banchereau J: Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid upregulation of B7-1 and B7-2. Immunity 1995;2:239-248.
63. Stamenkovic I, Seed B: The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990;345:74-77.
64. Pezzutto A, Dörken B, Moldenhauer G, Clark EA: Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J Immunol 1987;138:98-103.
65. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT: A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995;269:242-244.